Abstract:SIRT6 activation is thought to be a promising target for the treatment of many diseases, particularly cancer. Herein, we report the discovery of a series of new small-molecule SIRT6 activators. Structure–activity relationship analyses led to the identification of the most potent compound, 2-(1-benzofuran-2-yl)-N-(diphenylmethyl) quinoline-4-carboxamide (12q), which showed an EC1.5 value of 0.58 ± 0.12 μM and an EC50 value of 5.35 ± 0.69 μM against SIRT6-dependent peptide deacetylation in FLUOR DE LYS assay. It exhibited weak or no activity against other HDAC family members as well as 415 kinases, indicating good selectivity for SIRT6. 12q significantly inhibited the proliferation and migration of pancreatic ductal adenocarcinoma (PDAC) cells in vitro. It also markedly suppressed the tumor growth in a PDAC tumor xenograft model. This compound showed attractive pharmacokinetic properties. Overall, 12q could be a good lead compound for the treatment of PDAC, and it is worthy of further study.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c01183?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01183</a>.Activity data of 40 candidate compounds; predicted binding mode of Hit20 with SIRT6; dose-dependent activities of SIRT6 demyristoylation of 12q; predicted binding mode of 12q with SIRT6; other experimental data of compound 12qin vitro and in vivo; and 1H NMR spectra, 13C NMR spectra, HRMS data, and HPLC traces for key target compounds (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01183/suppl_file/jm0c01183_si_001.pdf">PDF</a>)SMILES molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01183/suppl_file/jm0c01183_si_002.csv">CSV</a>)Binding model of compound 12q with SIRT6 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c01183/suppl_file/jm0c01183_si_003.pdb">PDB</a>)This article has not yet been cited by other publications.

Identification of 2-hydroxybenzoic acid derivatives as selective SIRT5 inhibitors

Discovery of new human Sirtuin 5 inhibitors by mimicking glutaryl-lysine substrates

Design, synthesis and biological evaluation of 2,4,6- trisubstituted triazine derivatives as new nonpeptide small-molecule SIRT5 inhibitors

Specific Turn-On Fluorescent Probe With Aggregation-Induced Emission Characteristics For Sirt1 Modulator Screening And Living-Cell Imaging

Pharmacophore-guided in-silico discovery of SIRT1 inhibitors for targeted cancer therapy

Molecular Docking‐based Virtual Screening and Dynamics Simulation Study of Novel and Potential SIRT7 Inhibitors

New ε-N-thioglutaryl-lysine derivatives as SIRT5 inhibitors: Chemical synthesis, kinetic and crystallographic studies

Discovery of 2-((4,6-dimethylpyrimidin-2-yl)thio)-n-phenylacetamide Derivatives As New Potent and Selective Human Sirtuin 2 Inhibitors

2‐(Methyl(phenyl)amino)‐N‐(phenyloxyphenyl)acetamide structural motif representing a framework for selective SIRT2 inhibition

Discovery of 5-(Substituted Phenyl)-2-aryl Benzimidazole Derivatives as SIRT1 Activators: Their Design, in silico Studies, Synthesis, and in vitro Evaluation

Discovery of small molecule sirt1 activator using high-throughput virtual screening, molecular dynamics simulation, molecular mechanics generalized born/surface area (MM/GBSA) calculation, and biological evaluation

A homogeneous time-resolved fluorescence screen to identify SIRT2 deacetylase and defatty-acylase inhibitors

Discovery of Potent Small-Molecule SIRT6 Activators: Structure–Activity Relationship and Anti-Pancreatic Ductal Adenocarcinoma Activity

A fluorometric assay of SIRT1 deacetylation activity through quantification of nicotinamide adenine dinucleotide.

Design and Synthesis of Amino Acid Derivatives of Substituted Benzimidazoles and Pyrazoles as Selective Sirt1 Inhibitors

A bicyclic pentapeptide-based highly potent and selective pan-SIRT1/2/3 inhibitor harboring Nε-thioacetyl-lysine.

Mechanism-Based Inhibitors of the Human Sirtuin 5 Deacylase: Structure-Activity Relationship, Biostructural, and Kinetic Insight

Development of 1,2,4-Oxadiazoles as Potent and Selective Inhibitors of the Human Deacetylase Sirtuin 2: Structure–Activity Relationship, X-ray Crystal Structure, and Anticancer Activity

A dual recognition-based strategy employing Ni-modified metal-organic framework for in situ screening of SIRT1 inhibitors from Chinese herbs

Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5

Identification of small molecular inhibitors of SIRT3 by computational and biochemical approaches a potential target of breast cancer